- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04292665
Effects of Classical Massage and Benson Relaxation Exercise on Heart Failure Patients
September 20, 2021 updated by: Merve Gulbahar, Hacettepe University
Randomized Controlled Trial of Classical Massage and Benson Relaxation Exercise for Patients With Heart Failure
Patients with heart failure will be entered.
Participants will be randomized to one of three study arms: Arm 1: Classical massage, Arm 2: Relaxation, Arm 3: Control Hypothesis: Classical Massage and Benson Muscle Relaxation will decrease frequency, severity, discomfort of symptoms and improve quality of life.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Previous reports have revealed that classical massage and Benson relaxation exercise are promising for physiological parameters such as respiratory rate, pulse, blood pressure in heart failure patients.
On the other hand, research examining effects of these approaches on physical symptom status that is including dyspnea, orthopnea, fatigue, chest pain, peripheral edema, sleep problems and dizziness and quality of life is limited.
The present study investigates the effects of classical massage and Benson relaxation exercise in a single-site, 3-arm, randomized, controlled study of 96 patients with heart failure.
Arm 1: Classical massage; Arm 2: Benson relaxation exercise; Arm 3: Control.
The investigators hypothesize that Classical Massage and Benson relaxation exercise will decrease frequency, severity, discomfort of symptoms and improve quality of life.
Study Type
Interventional
Enrollment (Actual)
72
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ankara, Turkey, 06100
- Ankara University Medical Faculty Ibni Sina Hospital Cardiology Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Being at least primary school graduates,
- Being over 18 years old
- Being diagnosed Stage III-IV with heart failure
- Not using any other complementary or integrative therapy during the study period
Exclusion Criteria:
- Having an additional disease such as advanced stage chronic obstructive pulmonary disease, asthma, cancer
- Stage I-II diagnosed with heart failure
- Having an active thrombosis
- Having a coagulation problem
- Not volunteering to participate in the research
- Patients who have been hospitalized for 5 days or less and discharged before five days after the start of the application.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Classical Massage
Patients will receive a total of fourteen individual applied classical massage sessions, twice daily for seven days, each session lasting 30 minutes.
|
During the first interview, a booklet explaining the introduction, purpose, benefits and application steps of hand-foot massage will be given to the patients in the classical massage group.
Hand and foot massage will be applied to the patients for 30 minutes in the form of right hand five minutes, left hand five minutes, right foot ten minutes, left foot ten minutes, using liquid vaseline in each session twice a day in the patient's own bed with individual applied sessions by the researcher.
Patients will receive a total of 14 sessions of classical massage, twice a day, for seven days.
|
|
EXPERIMENTAL: Relaxation
Patients will receive a total of fourteen individual counseling sessions, in a quiet room, twice daily for seven days, each session lasting 20 minutes.
|
During the first interview, patients will be given a booklet explaining the description, purpose, benefits and application steps of the Benson relaxation exercise.
With individual counseling sessions, a total of 14 sessions of Benson relaxation exercises will be performed in a quiet room, twice a day for seven days, each session lasting 20 minutes.
At the beginning of the application, patients will focus on their breaths by taking slow and natural breaths with the researchers' commands and will quietly say to yourself the words of the focus, sound, sentence or prayer they choose, which are meaningful to them.
|
|
OTHER: Control
Patients will continue to receive standard nursing care and no further intervention will be made during the research.
|
Patients will continue to receive standard nursing care and no further intervention will be made during the research.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in symptom status
Time Frame: Baseline measurements, at the end of 7th day and two weeks after the completion of the interventions
|
Symptom status will be measured based on patient report by the Symptom Status Questionnaire-Heart Failure .
Higher score means increase in symptom burden.
|
Baseline measurements, at the end of 7th day and two weeks after the completion of the interventions
|
|
Change in quality of life
Time Frame: Baseline measurements, at the end of 7th day and two weeks after the completion of the interventions
|
Quality of live will be measured by the Minnesota Living with Heart Failure Questionnaire.
Higher scores on the scale mean worse quality of life.
|
Baseline measurements, at the end of 7th day and two weeks after the completion of the interventions
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Zehra Gok Metın, Assos.Prof., Hacettepe University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
October 15, 2019
Primary Completion (ACTUAL)
May 30, 2020
Study Completion (ACTUAL)
June 15, 2020
Study Registration Dates
First Submitted
March 1, 2020
First Submitted That Met QC Criteria
March 1, 2020
First Posted (ACTUAL)
March 3, 2020
Study Record Updates
Last Update Posted (ACTUAL)
September 27, 2021
Last Update Submitted That Met QC Criteria
September 20, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Indiana UniversityRecruitingCongestive Heart Failure | Congestive Heart Failure (CHF) | Congestive Heart Failure Chronic | Congestive Heart Failure(CHF)United States
-
University of Health Sciences LahoreRecruitingAcute Decompensated Heart Failure | Heart Failure, Diastolic | Heart Failure, SystolicPakistan
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
Lakeland Regional Health Systems, Inc.RecruitingHeart Failure | Heart Failure Acute | Acute Heart Failure (AHF) | Heart Failure - NYHA II - IVUnited States
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Eli Lilly and CompanyNot yet recruitingHeart Failure | Heart Failure, Diastolic | Heart Failure, SystolicUnited States, Japan
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
Clinical Trials on Classical Massage
-
Ankara Yildirim Beyazıt UniversityNot yet recruiting
-
Biruni UniversityCompleted
-
Eastern Mediterranean UniversityUnknown
-
Dokuz Eylul UniversityCompletedPain | Hemodynamic Instability | Massage | Endotracheal Aspiration | ReflexologyTurkey
-
Halic UniversityCompletedTrigger Point Pain, MyofascialTurkey
-
Ayça AytarActive, not recruitingPain | DisabilityTurkey (Türkiye)
-
Halic UniversityCompletedChronic Low-back PainTurkey
-
Eastern Mediterranean UniversityNot yet recruiting
-
University School of Physical Education in WroclawCompleted
-
Instituto Sexológico MurcianoCIAGO - Center for Comprehensive Gynecology and Obstetrics; Carmen Parra Pilates...Recruiting